| Average Daily Range |
| Avg Daily Range: |
$0.58 | 3.40%
|
| Avg Daily Range (30 D): |
$0.83 | 3.29%
|
| Avg Daily Range (90 D): |
$0.59 | 2.92%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.14M |
| Avg Daily Volume (30 D): |
2.32M |
| Avg Daily Volume (90 D): |
1.81M |
| Trade Size |
| Avg Trade Size (Sh.): |
100 |
| Avg Trade Size (Sh.) (30 D): |
72 |
| Avg Trade Size (Sh.) (90 D): |
76 |
| Institutional Trades |
| Total Inst.Trades: |
2,109 |
| Avg Inst. Trade: |
$2.04M |
| Avg Inst. Trade (30 D): |
$3.9M |
| Avg Inst. Trade (90 D): |
$3.37M |
| Avg Inst. Trade Volume: |
.16M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.62M |
| Avg Closing Trade (30 D): |
$7.72M |
| Avg Closing Trade (90 D): |
$5.04M |
| Avg Closing Volume: |
201.42K |
|
|
| News |
Nov 17, 2025 @ 1:00 PM
FDA Accepts Supplemental New Drug Application for ...
Source: Arcutis Biotherapeutics, Inc.
|
Nov 7, 2025 @ 9:00 PM
Arcutis Biotherapeutics Reports Inducement Grants ...
Source: Arcutis Biotherapeutics, Inc.
|
Oct 27, 2025 @ 8:00 PM
Arcutis to Present at Upcoming Investor Conference...
Source: Arcutis Biotherapeutics, Inc.
|
Oct 3, 2025 @ 8:00 PM
Arcutis Biotherapeutics Reports Inducement Grants ...
Source: Arcutis Biotherapeutics, Inc.
|
Sep 29, 2025 @ 8:00 PM
Arcutis Biotherapeutics to Host Virtual Investor D...
Source: Arcutis Biotherapeutics, Inc.
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.34
|
$.06
|
$-.13
|
|
Diluted EPS
|
$-.34
|
$.06
|
$-.13
|
|
Revenue
|
$ 317.93M
|
$ 99.22M
|
$ 81.5M
|
|
Gross Profit
|
$ 286.02M
|
$ 90.53M
|
$ 74.01M
|
|
Net Income / Loss
|
$ -44.32M
|
$ 7.41M
|
$ -15.89M
|
|
Operating Income / Loss
|
$ -38.25M
|
$ 8.53M
|
$ -14.61M
|
|
Cost of Revenue
|
$ 31.91M
|
$ 8.69M
|
$ 7.49M
|
|
Net Cash Flow
|
$ -87.92M
|
$ -25.53M
|
$ 19.13M
|
|
PE Ratio
|
|
|
|
|
|
|
